Edward D. Bashaw

First Consulting Group (United States) — United States

Medicine · Health Sciences

13h-index1.3kcitations33works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical studies and practices(12), Advancements in Transdermal Drug Delivery(8), Dermatology and Skin Diseases(6), Pharmacological Effects and Toxicity Studies(6), Pharmacogenetics and Drug Metabolism(3)

Publications33 total

The Maximum Usage Trial: From Inception to Standardization
AAPS introductions in the pharmaceutical sciences·2025
Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020
Clinical and Translational Science·2023· 1 citedOpen Access
Drug and Dosage Form Development: Regulatory Perspectives
2021· 1 cited
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients
JAMA·2020· 259 citedOpen Access
In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products
Therapeutic Innovation & Regulatory Science·2020· 18 cited
In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products
Therapeutic Innovation & Regulatory Science·2019· 9 cited
Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients
JAMA·2019· 300 citedOpen Access
Regulatory Perspective of Biomarker Bioanalysis During Drug Development
Bioanalysis·2019· 12 citedOpen Access
Issue Information
The Journal of Clinical Pharmacology·2018Open Access
Regulatory Perspectives in Pharmacometric Models of Osteoporosis
The Journal of Clinical Pharmacology·2018· 13 cited
A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long‐Term Safety
Clinical and Translational Science·2017· 5 citedOpen Access
A clinical pharmacology‐regulatory perspective on the approval of drugs for rare diseases
Clinical Pharmacology & Therapeutics·2016· 7 cited
Navigating sticky areas in transdermal product development
Journal of Controlled Release·2016· 26 cited
Teratogenic drugs and their drug interactions with hormonal contraceptives
Clinical Pharmacology & Therapeutics·2016· 6 cited
Maximal Usage Trial: An Overview of the Design of Systemic Bioavailability Trial for Topical Dermatological Products
Therapeutic Innovation & Regulatory Science·2014· 28 citedOpen Access
Bioanalytical Method Validation: Concepts, Expectations and Challenges in Small Molecule and Macromolecule—A Report of PITTCON 2013 Symposium
The AAPS Journal·2014· 4 citedOpen Access
Predicting Nonlinear Pharmacokinetics of Omeprazole Enantiomers and Racemic Drug Using Physiologically Based Pharmacokinetic Modeling and Simulation: Application to Predict Drug/Genetic Interactions
Pharmaceutical Research·2014· 32 cited
Regulatory Perspective of Bioanalysis from A Clinical Pharmacology Reviewer Standpoint: Do You See What I See?
Bioanalysis·2014· 6 cited
Current Challenges in Bioequivalence, Quality, and Novel Assessment Technologies for Topical Products
Pharmaceutical Research·2014· 87 cited
Applications of dermal microdialysis: a review
Journal of Drug Delivery Science and Technology·2014· 17 cited
page 1 of 2Next →

Frequent Co-authors

Chinmay Shukla(7), Eva Benfeldt(5), Hartmut Derendorf(4), Vinod P. Shah(4), Luke S. Oh(4), Chandra S. Chaurasia(3), Markus Müller(3), Jan Bolinder(3), Ross Bullock(3), Peter M. Bungay(3), Elizabeth C. M. DeLange(3), William F. Elmquist(3), Margareta Hammarlund‐Udenaes(3), Christian Joukhadar(3), Dean L. Kellogg(3), Craig E. Lunte(3), Carl Nordstrom(3), Hans Rollema(3), Ronald J. Sawchuk(3), Belinda W.Y. Cheung(3)